O

Okairos S.R.L

10 employees

Okairos AG is a biopharmaceutical company focused on the discovery and development of genetic T-cell vaccines, including hepatitis C virus.

Basic info

Industry

research services

Sectors

Biotechnology
Health Care
Genetics
Medical
Pharmaceutical
Biopharma

Date founded

2007

Funding rounds raised

Total raised

$21M

from 3 investors over 3 rounds

O

Okairos S.R.L raised $21M on September 14, 2010

Investors: Versant Ventures

O

Okairos S.R.L raised $9.6M on March 19, 2007

Investors: EQT Life Sciences and BioMedPartners

FAQ